Benutzer: Gast  Login
Titel:

Switch from aprotinin to ?-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery.

Dokumenttyp:
Journal Article; Article
Autor(en):
Martin, K; Gertler, R; Liermann, H; Mayr, NP; Macguill, M; Schreiber, C; Vogt, M; Tassani, P; Wiesner, G
Abstract:
With the withdrawal of aprotinin from worldwide marketing in November 2007, many institutions treating patients at high risk for hyperfibrinolysis had to update their therapeutic protocols. At our institution, the standard was switched from aprotinin to ?-aminocaproic acid (EACA) in all patients undergoing cardiac surgery with extracorporeal circulation including neonates. Although both antifibrinolytic medications have been used widely for many years, there are few data directly comparing their...     »
Zeitschriftentitel:
Br J Anaesth
Jahr:
2011
Band / Volume:
107
Heft / Issue:
6
Seitenangaben Beitrag:
934-9
Sprache:
eng
Volltext / DOI:
doi:10.1093/bja/aer267
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/21857014
Print-ISSN:
0007-0912
TUM Einrichtung:
Fachgebiet Kardioanästhesie (Prof. Tassani-Prell); Klinik für Herz- und Gefäßchirurgie (Prof. Lange)
 BibTeX